EAACI Congress 2024
BackFT 21 - Flash talks on ENT – ear, nose, and throat
Sunday 02 Jun, 16:45 PM -
18:15 PM Valencia, Spain
Palma
Flash Talks
16:45
Pre-treating allergic rhinitis sufferers with fexofenadine before allergen exposure
16:52
The Prevalence of NSAID‐exacerbated Respiratory Disease in one allergy center from China: Diagnosis adhering to EAACI Position Paper
16:59
Respiratory Functions of Preschool-Age Children With Mouth Breathing Evaluated by Using Impulse Oscillometry
17:06
Infection History and Risk of Chronic Inflammatory Airway Diseases; A Real-World Hospital Cohort Study
17:13
Evaluation of the clinical benefit of a pollen and allergy app in Augsburg, Southern Germany: a stratified, controlled intervention study
17:20
Efficacy of Dupliuzumab in the treatment of atopic dermatitis complicated by chronic rhinosinusitis with nasal polyps
17:27
Fexofenadine: Why fexofenadine is considered non-sedating: A systematic review
17:34
Clinical and histological differences between choanal polyps in children and adults: analysis of a 15-year series of patients treated at our institution
17:41
Baseline Disease Characteristics Among Patients with Chronic Rhinosinusitis with Nasal Polyps and Coexisting Asthma in the Global AROMA Registry
17:48
Deep immune profiling of chronic rhinosinusitis in allergic and non-allergic cohorts using mass cytometry
17:55
Proteomic analysis identifies patients with chronic rhinosinusitis with nasal polyps who are responders and non-responders to benralizumab (NAPPREB study)
18:02
Characteristics of patients with chronic rhinosinusitis with nasal polyps and allergic rhinitis enrolled in the global AROMA registry
